Benzinga | Jul 31, 2020 07:19AM EDT

Apellis Pharmaceuticals Q2 EPS $1.57 Up From $(1.12) YoY

Apellis Pharmaceuticals (NASDAQ:APLS) reported quarterly earnings of $1.57 per share. This is a 240.18 percent increase over losses of $(1.12) per share from the same period last year.